MENU
EVO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Evotec SE (EVO) Ownership - Who owns Evotec SE?
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more
Profile
Industry
N/A
Address
Essener Bogen 7
Phone
+49 40560810
Employees
4952
Web
https://www.evotec.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
2.77B
P/E Ratio
476.19
Total Cash
619.18M
Projected Growth
N/A
Total Debt
588.74M
Revenue
820.8M
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash/Share
1.75
Total Debt/Equity
N/A
Revenue/Share
2.51 USD as % of share price
Fundamentals
EVO
Capitalization
2.77B
P/E Ratio
476.19
Risk (Beta)
1.80
Dividend Yield
N/A
Total Cash
619M
Total Cash/Share
1.75
Total Debt
589M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.51%
Revenue
821M
ROE
N/A
Book Value
1.14B
P/B Ratio
2.22
Cash Flow
N/A
Earnings
-0.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
177M
Current Ratio
2.16
Current Revenue Per Employee
38591.82
Dividends Per Share - Security
N/A
EBITDA
-63.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
19.27
Revenue To Assets
-4.21
Shares Held By Institutions
81.9M
Shares Outstanding - Current
354M
Total Liabilities
1.11B
Total Volume MTD
N/A
Value
-1
Gain YTD
-9.856
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EVO showed earnings on May 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
N/A
Address
Essener Bogen 7
Phone
+49 40560810
Employees
4952
Web
https://www.evotec.com